Zur Startseite gehen
0,00 €*
Cover: 9780128215951 | RNA Therapeutics | The Evolving Landscape of RNA Therapeutics | Buch
Dekorationsartikel gehören nicht zum Leistungsumfang.
RNA Therapeutics
The Evolving Landscape of RNA Therapeutics
Taschenbuch von John J. Rossi (u. a.)
Sprache: Englisch

187,95 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 1-2 Wochen

Kategorien:
Beschreibung
Provides a comprehensive overview of RNA therapeutic modalities, from bench-to-bedside, with an emphasis on the increasingly impactful areas of gene therapy, oligonucleotide therapeutics, gene editing and delivery. International leaders in the field examine RNA-based therapeutics tools that have been developed to-date to modulate cellular processes such as transcription, translation and protein function. Approved RNA-based therapies and lessons learned from failed therapies are discussed in-depth, as are evolving advances in RNA biochemical analysis, and similar advances that are enabling clinical application of RNA-based therapies. Later sections discuss delivery technologies, remaining hurdles in research and translation, the therapy development process from the lab to the clinic, and novel RNA-based therapies currently in development.
Provides a comprehensive overview of RNA therapeutic modalities, from bench-to-bedside, with an emphasis on the increasingly impactful areas of gene therapy, oligonucleotide therapeutics, gene editing and delivery. International leaders in the field examine RNA-based therapeutics tools that have been developed to-date to modulate cellular processes such as transcription, translation and protein function. Approved RNA-based therapies and lessons learned from failed therapies are discussed in-depth, as are evolving advances in RNA biochemical analysis, and similar advances that are enabling clinical application of RNA-based therapies. Later sections discuss delivery technologies, remaining hurdles in research and translation, the therapy development process from the lab to the clinic, and novel RNA-based therapies currently in development.
Inhaltsverzeichnis
SECTION 1 The world of RNA therapeutics: Available RNA tools to modulate cellular processes
1. Targeting chromatin: Transcriptional gene activation (saRNA)
2. Argonaute and TNRC6, partners in RNAi
3. Targeted RNA therapeutics for treatment of cancer and immunomodulation
4. Extrahepatic delivery of RNA to immune cells SECTION 2 Learning from history
5. Aptamer-based protein inhibitors
6. Lessons learned from developing an oligonucleotide drug for a rare disease SECTION 3 Delivery
7. Nucleoside modifications of in vitro transcribed mRNA to reduce immunogenicity and improve translation of prophylactic and therapeutic antigens
8. SOMAmer reagents and the SomaScan platform: Chemically modified aptamers and their applications in therapeutics, diagnostics, and proteomics SECTION 4 From bench to bedside
9. CMC and regulatory aspects of oligonucleotide therapeutics
10. CMC: Regulatory landscape
11. CMC and manufacturing SECTION 5 From bench to bedside12. RNA delivery for cancer gene therapy
13. Combinatorial RNA therapies in cancer immunotherapy: Challenges and directions
Details
Erscheinungsjahr: 2022
Fachbereich: Biophysik
Genre: Biologie, Importe
Rubrik: Naturwissenschaften & Technik
Medium: Taschenbuch
Inhalt: Kartoniert / Broschiert
ISBN-13: 9780128215951
ISBN-10: 012821595X
Sprache: Englisch
Einband: Kartoniert / Broschiert
Redaktion: Rossi, John J.
Giangrande, Paloma H.
de Franciscis, Vittorio
Hersteller: Elsevier Science Publishing Co Inc
Verantwortliche Person für die EU: Produktsicherheitsverantwortliche/r, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de
Maße: 188 x 480 x 32 mm
Von/Mit: John J. Rossi (u. a.)
Erscheinungsdatum: 13.04.2022
Gewicht: 0,984 kg
Artikel-ID: 119380244
Inhaltsverzeichnis
SECTION 1 The world of RNA therapeutics: Available RNA tools to modulate cellular processes
1. Targeting chromatin: Transcriptional gene activation (saRNA)
2. Argonaute and TNRC6, partners in RNAi
3. Targeted RNA therapeutics for treatment of cancer and immunomodulation
4. Extrahepatic delivery of RNA to immune cells SECTION 2 Learning from history
5. Aptamer-based protein inhibitors
6. Lessons learned from developing an oligonucleotide drug for a rare disease SECTION 3 Delivery
7. Nucleoside modifications of in vitro transcribed mRNA to reduce immunogenicity and improve translation of prophylactic and therapeutic antigens
8. SOMAmer reagents and the SomaScan platform: Chemically modified aptamers and their applications in therapeutics, diagnostics, and proteomics SECTION 4 From bench to bedside
9. CMC and regulatory aspects of oligonucleotide therapeutics
10. CMC: Regulatory landscape
11. CMC and manufacturing SECTION 5 From bench to bedside12. RNA delivery for cancer gene therapy
13. Combinatorial RNA therapies in cancer immunotherapy: Challenges and directions
Details
Erscheinungsjahr: 2022
Fachbereich: Biophysik
Genre: Biologie, Importe
Rubrik: Naturwissenschaften & Technik
Medium: Taschenbuch
Inhalt: Kartoniert / Broschiert
ISBN-13: 9780128215951
ISBN-10: 012821595X
Sprache: Englisch
Einband: Kartoniert / Broschiert
Redaktion: Rossi, John J.
Giangrande, Paloma H.
de Franciscis, Vittorio
Hersteller: Elsevier Science Publishing Co Inc
Verantwortliche Person für die EU: Produktsicherheitsverantwortliche/r, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de
Maße: 188 x 480 x 32 mm
Von/Mit: John J. Rossi (u. a.)
Erscheinungsdatum: 13.04.2022
Gewicht: 0,984 kg
Artikel-ID: 119380244
Sicherheitshinweis

Ähnliche Produkte

Diese Website verwendet Cookies, um eine bestmögliche Erfahrung bieten zu können. Mehr Informationen ...